| |
| |
|
| Insider
Information: |
Jacob Leonard S |
| Relationship: |
Director |
| City: |
Blue Bell |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -23.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bradley Pharmaceuticals Inc |
BDY |
Director |
2007-03-30 |
1,000 |
2007-03-30 |
0 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
Director |
2022-05-24 |
0 |
2007-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2022-05-24 |
4 |
D |
$5.60 |
$955,220 |
D/D |
(170,575) |
0 |
0 |
- |
|
| BDY |
Bradley Pharmaceuticals I... |
Director |
– • – |
2007-03-30 |
4 |
B |
$19.05 |
$19,050 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2007-08-20 |
4 |
B |
$1.29 |
$12,900 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2007-11-19 |
4 |
B |
$1.09 |
$5,450 |
D/D |
5,000 |
15,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2007-11-20 |
4 |
B |
$1.09 |
$5,450 |
D/D |
5,000 |
20,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2008-11-17 |
4 |
B |
$0.48 |
$9,600 |
D/D |
20,000 |
40,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2009-12-15 |
4 |
B |
$1.07 |
$5,350 |
D/D |
5,000 |
45,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2010-03-26 |
4 |
B |
$1.45 |
$7,250 |
D/D |
5,000 |
50,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2010-08-16 |
4 |
B |
$1.59 |
$7,950 |
D/D |
5,000 |
55,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2011-04-13 |
4 |
B |
$1.58 |
$15,840 |
D/D |
10,000 |
65,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2011-08-12 |
4 |
B |
$2.06 |
$4,120 |
D/D |
2,000 |
67,000 |
2.31 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2011-12-22 |
4 |
B |
$1.79 |
$8,950 |
D/D |
5,000 |
72,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2012-11-16 |
4 |
B |
$3.44 |
$34,390 |
D/D |
10,000 |
82,000 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2013-05-17 |
4 |
S |
$4.00 |
$68,000 |
D/D |
(17,000) |
126,829 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2014-01-15 |
4 |
AS |
$5.05 |
$57,571 |
D/D |
(11,400) |
126,829 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
61,829 |
133,829 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2014-01-15 |
4 |
OE |
$0.50 |
$5,700 |
D/D |
11,400 |
138,229 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2015-03-23 |
4 |
S |
$2.68 |
$51,188 |
D/D |
(19,100) |
168,885 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2013-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
55,556 |
182,385 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2015-03-20 |
4 |
S |
$2.69 |
$11,836 |
D/D |
(4,400) |
187,985 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2014-08-11 |
4 |
B |
$1.98 |
$19,800 |
D/D |
10,000 |
192,385 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2017-10-09 |
4 |
AS |
$4.05 |
$931,920 |
D/D |
(230,000) |
207,485 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2019-12-09 |
4 |
S |
$4.62 |
$1,133,145 |
D/D |
(244,814) |
212,749 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2016-03-18 |
4 |
B |
$0.72 |
$36,000 |
D/D |
50,000 |
218,885 |
2.39 |
- |
|
| ATRS |
Antares Pharma Inc |
Director |
– • – |
2016-12-01 |
4 |
AS |
$1.97 |
$39,416 |
D/D |
(20,000) |
218,885 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
